Neuca (WAR:NEU) Piotroski F-Score: 7 (As of Jun. 28, 2026) — 17% Above Median


WAR:NEU Neuca SA WAR:NEU
97 GF Score
Price zł718.00
GF Value zł888.72
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Neuca Piotroski F-Score?

Neuca WAR:NEU +0.14% 97 Piotroski F-Score is 7 as of Jun. 28, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates WAR:NEU with a GF Score™ of 97/100 and a GF Value™ of zł888.72 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 112 Medical Distribution companies, Neuca ranks better than 89.29% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Neuca has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Neuca's Piotroski F-Score or its related term are showing as below:

WAR:NEU' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 8
Current: 7

During the past 13 years, the highest Piotroski F-Score of Neuca was 8. The lowest was 3. And the median was 6.

Neuca  (WAR:NEU) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Neuca Piotroski F-Score Related Terms


Neuca Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Neuca's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuca Piotroski F-Score Chart

Neuca Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 6.00 6.00 5.00 5.00

Neuca Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 6.00 5.00 5.00 7.00

WAR:NEU vs MCK, COR, CAH: Piotroski F-Score Comparison

For the Medical Distribution subindustry, Neuca's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuca Piotroski F-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Neuca's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Neuca's Piotroski F-Score falls into.


WAR:NEU
97GF Score
Neuca SA WAR:NEU
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 19.847 + 60.246 + 27.119 + 68.342 = zł176 Mil.
Cash Flow from Operations was 187.443 + 89.732 + 168.952 + -5.164 = zł441 Mil.
Revenue was 3268.038 + 3488.826 + 3520.863 + 3556.906 = zł13,835 Mil.
Gross Profit was 374.739 + 400.635 + 392.249 + 428.001 = zł1,596 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(5461.684 + 5578.295 + 5976.513 + 6242.08 + 6135.546) / 5 = zł5878.8236 Mil.
Total Assets at the begining of this year (Mar25) was zł5,462 Mil.
Long-Term Debt & Capital Lease Obligation was zł149 Mil.
Total Current Assets was zł4,038 Mil.
Total Current Liabilities was zł4,493 Mil.
Net Income was 30.62 + 41.869 + 25.34 + 48.367 = zł146 Mil.

Revenue was 3043.423 + 3185.245 + 3220.956 + 3365.888 = zł12,816 Mil.
Gross Profit was 355.407 + 369.544 + 352.699 + 390.722 = zł1,468 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(5216.612 + 5225.571 + 5570.065 + 5510.182 + 5461.684) / 5 = zł5396.8228 Mil.
Total Assets at the begining of last year (Mar24) was zł5,217 Mil.
Long-Term Debt & Capital Lease Obligation was zł145 Mil.
Total Current Assets was zł3,511 Mil.
Total Current Liabilities was zł3,716 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Neuca's current Net Income (TTM) was 176. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Neuca's current Cash Flow from Operations (TTM) was 441. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=175.554/5461.684
=0.03214283

ROA (Last Year)=Net Income/Total Assets (Mar24)
=146.196/5216.612
=0.02802509

Neuca's return on assets of this year was 0.03214283. Neuca's return on assets of last year was 0.02802509. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Neuca's current Net Income (TTM) was 176. Neuca's current Cash Flow from Operations (TTM) was 441. ==> 441 > 176 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=148.963/5878.8236
=0.02533891

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=145.084/5396.8228
=0.02688322

Neuca's gearing of this year was 0.02533891. Neuca's gearing of last year was 0.02688322. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=4038.153/4493.384
=0.89868861

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=3511.015/3715.934
=0.94485397

Neuca's current ratio of this year was 0.89868861. Neuca's current ratio of last year was 0.94485397. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Neuca's number of shares in issue this year was 4.626. Neuca's number of shares in issue last year was 4.577. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1595.624/13834.633
=0.11533548

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1468.372/12815.512
=0.11457771

Neuca's gross margin of this year was 0.11533548. Neuca's gross margin of last year was 0.11457771. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=13834.633/5461.684
=2.53303432

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=12815.512/5216.612
=2.45667341

Neuca's asset turnover of this year was 2.53303432. Neuca's asset turnover of last year was 2.45667341. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+0+1+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Neuca has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Neuca (WAR:NEU) has a Piotroski F-Score of 7 as of Jun. 28, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Neuca and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Neuca's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Neuca ranks #12 out of 112 companies in the Medical Distribution industry, placing it in the top 10.7%.
Is Neuca's Piotroski F-Score too high?
Neuca's current Piotroski F-Score of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Medical Distribution industry median Piotroski F-Score is 5.00. Neuca's value of 7 is 40% above this industry median. Based on the distribution chart, Neuca ranks #12 out of 112 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Neuca has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neuca's Piotroski F-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Neuca ranks #12 out of 112 companies for Piotroski F-Score. This places Neuca in the top 11% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Neuca's value of 7 is 40% above this benchmark. Historically, Neuca's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Neuca has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Distribution company?
The median Piotroski F-Score among Medical Distribution companies is 5.00, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neuca's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Neuca and its competitors. For the Medical Distribution industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neuca's current Piotroski F-Score is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuca stock overvalued right now?
Based on GuruFocus' analysis, Neuca (WAR:NEU) is currently considered Modestly Undervalued. The stock's GF Value™ is zł888.72, compared to a current price of zł718.00 — trading 19.2% below its estimated fair value. The current Piotroski F-Score is 7, which is 17% above median its 10-year median of 6.00 and 40% above the Medical Distribution industry median of 5.00. Neuca's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Neuca (WAR:NEU), the current Piotroski F-Score is 7 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuca (WAR:NEU) Overvalued in 2026?

Based on GuruFocus' analysis, Neuca stock appears to be undervalued. The current stock price of zł718.00 is trading 19.2% below its estimated GF Value™ of zł888.72. GuruFocus considers Neuca to be Modestly Undervalued.

Key valuation signals for WAR:NEU:

  • Piotroski F-Score: 7 (17% above median its 10-year median of 6.00)
  • GF Value™: zł888.72 vs. price of zł718.00 (19.2% below fair value)
  • GF Score™: 97/100 with 4 warning signs
  • Industry Position: 40% above the Medical Distribution median (#12 of 112)

No single metric tells the full story. See the WAR:NEU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Neuca Business Description

Address ul. Forteczna 35‑37, Torun, POL, 87-100
Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.
97GF Score

Get the complete analysis for WAR:NEU

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł718.00
Price
zł888.72
GF Value